X hits on this document

89 views

0 shares

0 downloads

0 comments

10 / 30

Tykerb was selected for progression to clinical trials based on 22 selection criteria which included:

  • Efficacy parameters (cellular and in vivo)

  • Biometabolism parameters (time of drug exposure, %F, p450 enzymes)

  • Toxicity (cellular, cardiovascular, 7 day rat studies, Ames, etc)

  • Chemical issues (cost of goods and scaleability)

Document info
Document views89
Page views89
Page last viewedThu Dec 08 00:52:15 UTC 2016
Pages30
Paragraphs319
Words1235

Comments